Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results in earlier phases ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

MRNA intends to use the funds to support the development of its mRNA-based bird flu shot and expand clinical studies for ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Merck stands to lose $62 billion over four years following the loss of exclusivity on KEYTRUDA, making Moderna's $13 billion market cap a bargain. The worsening Avian Flu crisis adds optionality ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

Moderna's stock is down 36.63% due to poor COVID-19 vaccine sales and lack of promising alternatives, but bird flu presents asymmetric upside potential. The company's cost-cutting measures may ...